CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-383

Interesting point. It is quite clear that this company has significant operating leverage, a small increase in scale can have a big impact when it comes to the bottom line profitability figures. With the amount of growth they have recorded, I am sure that there has indeed been a material improvement in the operating results, as indicated by the company. You also mention that the audited results will be picked up by the institutional algorithms and scanners, well this should be particularly true this year. Not only will the incredible growth be quite appealing for these larger investors, the actual improvement in the profit figure will be exaggerated due to the fact that last year, the profit figure was significantly distorted by a very large, one off, non cash impairment that made it appear as if the company recorded a far larger loss than was really the case. In reality, the operating result improved last year, but that improvement was hidden by this large one off non-cash item. Regardless, to the algorithms, the change from last year to this year should appear massively bullish. This should really get the attention of the institutional investors, and set off alarm bells at their trading desks to buy buy buy!

The previous unaudited results would likely only have been viewed by existing investors, the audited results will really generate the noise. Not long left to go now, next week perhaps